Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Usefulness of Serial Blood Sampling and PCR Replicates for Treatment Monitoring of Patients with Chronic Chagas Disease.

Parrado R, Ramirez JC, de la Barra A, Alonso-Vega C, Juiz N, Ortiz L, Illanes D, Torrico F, Gascon J, Alves F, Flevaud L, Garcia L, Schijman AG, Ribeiro I.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01191-18. doi: 10.1128/AAC.01191-18. Print 2019 Feb.

2.

First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease.

Ramírez JC, Parrado R, Sulleiro E, de la Barra A, Rodríguez M, Villarroel S, Irazu L, Alonso-Vega C, Alves F, Curto MA, García L, Ortiz L, Torrico F, Gascón J, Flevaud L, Molina I, Ribeiro I, Schijman AG.

PLoS One. 2017 Nov 27;12(11):e0188550. doi: 10.1371/journal.pone.0188550. eCollection 2017.

3.

Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?

Picado A, Angheben A, Marchiol A, Alarcón de Noya B, Flevaud L, Pinazo MJ, Gállego M, Meymandi S, Moriana S.

PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005148. doi: 10.1371/journal.pntd.0005148. eCollection 2017 Jan. No abstract available.

4.

Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study.

Bisser S, Lumbala C, Nguertoum E, Kande V, Flevaud L, Vatunga G, Boelaert M, Büscher P, Josenando T, Bessell PR, Biéler S, Ndung'u JM.

PLoS Negl Trop Dis. 2016 Apr 8;10(4):e0004608. doi: 10.1371/journal.pntd.0004608. eCollection 2016 Apr.

5.

Using BD Vacutainer CD4 Stabilization Tubes for Absolute Cluster of Differentiation Type 4 Cell Count Measurement on BD FacsCount and Partec Cyflow Cytometers: A Method Comparison Study from Zimbabwe.

Vogt F, Van den Bergh R, Bernasconi A, Moyo B, Havazvidi L, Bastard M, Flevaud L, Taziwa F, Makondo E, Mtapuri-Zinyowera S.

PLoS One. 2015 Aug 21;10(8):e0136537. doi: 10.1371/journal.pone.0136537. eCollection 2015.

6.

Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.

Porrás AI, Yadon ZE, Altcheh J, Britto C, Chaves GC, Flevaud L, Martins-Filho OA, Ribeiro I, Schijman AG, Shikanai-Yasuda MA, Sosa-Estani S, Stobbaerts E, Zicker F.

PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003697. doi: 10.1371/journal.pntd.0003697. eCollection 2015 Jun. No abstract available.

7.

Comparative evaluation of 11 commercialized rapid diagnostic tests for detecting Trypanosoma cruzi antibodies in serum banks in areas of endemicity and nonendemicity.

Sánchez-Camargo CL, Albajar-Viñas P, Wilkins PP, Nieto J, Leiby DA, Paris L, Scollo K, Flórez C, Guzmán-Bracho C, Luquetti AO, Calvo N, Tadokoro K, Saez-Alquezar A, Palma PP, Martin M, Flevaud L.

J Clin Microbiol. 2014 Jul;52(7):2506-12. doi: 10.1128/JCM.00144-14. Epub 2014 May 7.

8.

Monitoring HIV viral load in resource limited settings: still a matter of debate?

Arnedo M, Alonso E, Eisenberg N, Ibáñez L, Ferreyra C, Jaén A, Flevaud L, Khamadi S, Roddy P, Gatell JM, Dalmau D; Busia O R Study Group.

PLoS One. 2012;7(12):e47391. doi: 10.1371/journal.pone.0047391. Epub 2012 Dec 6.

9.

Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.

Ferreyra C, Yun O, Eisenberg N, Alonso E, Khamadi AS, Mwau M, Mugendi MK, Alvarez A, Velilla E, Flevaud L, Arnedo M, Dalmau D, Roddy P, Bernasconi A, Palma PP.

PLoS One. 2012;7(11):e49834. doi: 10.1371/journal.pone.0049834. Epub 2012 Nov 21.

10.

Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis.

Priotto G, Chappuis F, Bastard M, Flevaud L, Etard JF.

PLoS Negl Trop Dis. 2012;6(6):e1662. doi: 10.1371/journal.pntd.0001662. Epub 2012 Jun 5.

11.
12.

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.

Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R, Kumar P, Kumar R, Das P, Mitra G, Flevaud L, Ferreyra C, Remartinez D, Pece M, Palma PP.

Clin Infect Dis. 2011 Oct;53(7):e91-8. doi: 10.1093/cid/cir521.

PMID:
21890763
13.

NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.

Yun O, Priotto G, Tong J, Flevaud L, Chappuis F.

PLoS Negl Trop Dis. 2010 May 25;4(5):e720. doi: 10.1371/journal.pntd.0000720. Review. No abstract available.

14.

Human African trypanosomiasis in areas without surveillance.

Chappuis F, Lima MA, Flevaud L, Ritmeijer K.

Emerg Infect Dis. 2010 Feb;16(2):354-6. doi: 10.3201/eid1602.090967. No abstract available.

15.

Natural history of a visceral leishmaniasis outbreak in highland Ethiopia.

Herrero M, Orfanos G, Argaw D, Mulugeta A, Aparicio P, Parreño F, Bernal O, Rubens D, Pedraza J, Lima MA, Flevaud L, Palma PP, Bashaye S, Alvar J, Bern C.

Am J Trop Med Hyg. 2009 Sep;81(3):373-7.

PMID:
19706898
16.

Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.

Yun O, Lima MA, Ellman T, Chambi W, Castillo S, Flevaud L, Roddy P, Parreño F, Albajar Viñas P, Palma PP.

PLoS Negl Trop Dis. 2009 Jul 7;3(7):e488. doi: 10.1371/journal.pntd.0000488.

17.

Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood.

Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, Lima N, Villa L, Torrico F, Albajar-Viñas P.

J Clin Microbiol. 2008 Jun;46(6):2022-7. doi: 10.1128/JCM.02303-07. Epub 2008 Apr 9.

Supplemental Content

Loading ...
Support Center